https://feeds.newsfilecorp.com/company/12443 Latest news from Tevard Biosciences, as distributed by TMX Newsfile. en CopyRight (c) 2026, Newsfile Corp. All Rights Reserved. office@newsfilecorp.com (Newsfile Corp.) office@newsfilecorp.com (Newsfile Corp.) Wed, 09 Sep 2026 14:30:09 -0400 https://images.newsfilecorp.com/logos/12443.jpg https://feeds.newsfilecorp.com/company/12443 https://www.newsfilecorp.com/release/313678/Tevard-Biosciences-Announces-Publication-of-Preclinical-Research-Supporting-Engineered-Suppressor-tRNAs-for-Duchenne-Muscular-Dystrophy Boston, Massachusetts--(Newsfile Corp. - September 9, 2026) - Tevard Biosciences, Inc., a biotechnology company pioneering tRNA-based therapies to cure a broad range of genetic diseases, today highlighted the publication of research conducted by scientists at Tevard Biosciences, Johns Hopkins University, MIT, and the Whitehead Institute for Biomedical Research in Science Advances. The paper, entitled "Engineering suppressor tRNAs for effective treatment of Duchenne Muscular...<img src="https://api.newsfilecorp.com/newsinfo/313678/156" id="156" width="2" height="2" style="width: 1px; height: 1px;border: 0px solid;" /> Wed, 09 Sep 2026 14:27:00 -0400 en https://www.newsfilecorp.com/release/313678